new glp-1 receptor agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Frontiers | GLP-1 Receptor Agonists:

Pharmacol Res, 2025

It is a structural feature of the US healthcare system that has been in place for years and will remain in place at least partially for years more

In addition, the psychiatric AEs from GLP-1 RA treatment are primarily from self-reporting by consumers, and the increase in the number of AEs could be attributed to the expansion of the indications for GLP-1 RAs and the increased awareness of psychiatric AEs among healthcare professionals and patients during post-market surveillance

Prioritize and track water stewardship and supplier engagement

Obesity is independently associated with cardiovascular morbidity and mortality and is estimated to cost the health system over $200 billion dollars annually

Start the conversation with your clinical provider about what happens to your care if the regulatory situation changes